Rapid and sustained autologous neutralizing response leading to early spontaneous recovery after HCV infection

Virology

Volumn 444, Issue 1-2, 2013, Pages 90-99

  Esteban Riesco, Laura ^a   Depaulis, Frantz ^b   Moreau, Alain ^a   Bacq, Yannick ^c   Dubois, Frédéric ^d   Goudeau, Alain ^a,d   Gaudy Graffin, Catherine ^a,d  

^a UNIVERSITÉ DE TOURS   (France)

^b ECOLE NORMALE SUPÉRIEURE   (France)

^c SERVICE DE DERMATOLOGIE   (France)

^d CHU BRETONNEAU   (France)

Author keywords

Autologous; Clearance; Evolution; Hepatitis C; Neutralization; Primoinfection

Indexed keywords

ALANINE AMINOTRANSFERASE; GLYCOPROTEIN E1; GLYCOPROTEIN E2; NEUTRALIZING ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; AUTOLOGOUS NEUTRALIZING RESPONSE; BLOOD SAMPLING; CASE REPORT; CONTROLLED STUDY; CONVALESCENCE; EMBRYO; FEMALE; GENETIC VARIABILITY; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION CONTROL; MALE; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRAL CLEARANCE; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

AUTOLOGOUS; CLEARANCE; EVOLUTION; HEPATITIS C; NEUTRALIZATION; PRIMOINFECTION;

ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; EVOLUTION, MOLECULAR; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TIME FACTORS; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS;

EID: 84882861458     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.05.037     Document Type: Article

References (47)

1. Alter M.J. Epidemiology of hepatitis C virus infection. World J. Gastroenterol. 2007, 13:2436-2441.
2. Anisimova M., Nielsen R., Yang Z. Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. Genetics 2003, 164:1229-1236.
3. Awadalla P., Eyre-Walker A., Smith J.M. Linkage disequilibrium and recombination in hominid mitochondrial DNA. Science 1999, 286:2524-2525.
4. Bartosch B., Dubuisson J., Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 2003, 197:633-642.
5. Brown R.J.P., Juttla V.S., Tarr A.W., Finnis R., Irving W.L., Hemsley S., Flower D.R., Borrow P., Ball J.K. Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection. J. Gen. Virol. 2005, 86:1931-1942.
6. Bukh J., Miller R.H., Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 1995, 15:41-63.
7. Delport W., Scheffler K., Seoighe C. Models of coding sequence evolution. Brief. Bioinf. 2009, 10:97-109.
8. Di Lorenzo C., Angus A.G.N., Patel A.H. Hepatitis C virus evasion mechanisms from neutralizing antibodies. Viruses 2011, 3:2280-2300.
9. Dowd K.A., Netski D.M., Wang X.H., Cox A.L., Ray S.C. Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. Gastroenterology 2009, 136:2377-2386.
10. Edwards V.C., Tarr A.W., Urbanowicz R.A., Ball J.K. The role of neutralizing antibodies in hepatitis C virus infection. J. Gen. Virol. 2012, 93:1-19.
11. Falkowska E., Kajumo F., Garcia E., Reinus J., Dragic T. Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization. J. Virol. 2007, 81:8072-8079.
12. Farci P., Purcell R.H. Clinical significance of hepatitis C virus genotypes and quasispecies. Semin. Liver Dis. 2000, 20:103-126.
13. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J.C., Strazzera A., Chien D.Y., Munoz S.J., Balestrier A., Purcell R.H., Alter H.J. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000, 288:339-344.
14. Flint M., Logvinoff C., Rice C.M., McKeating J.A. Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins. J. Virol. 2004, 78:6875-6882.
15. Gaudy-Graffin C., Lesage G., Kousignian I., Laperche S., Girault A., Dubois F., Goudeau A., Barin F. Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection. J. Clin. Microbiol. 2010, 48:3281-3287.
16. Guindon S., Lethiec F., Duroux P., Gascuel O. PHYML Online-a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res. 2005, 33:W557-559.
17. Helle F., Goffard A., Morel V., Duverlie G., McKeating J., Keck Z.Y., Foung S., Penin F., Dubuisson J., Voisset C. The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein. J. Virol. 2007, 81:8101-8111.
18. Helle F., Vieyres G., Elkrief L., Popescu C.I., Wychowski C., Descamps V., Castelain S., Roingeard P., Duverlie G., Dubuisson J. Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions. J. Virol. 2010, 84:11905-11915.
19. Hoshino H., Hino K., Miyakawa H., Takahashi K., Akbar S.M.F., Mishiro S. Inter-genotypic recombinant hepatitis C virus strains in Japan noted by discrepancies between immunoassay and sequencing. J. Med. Virol. 2012, 84:1018-1024.
20. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C.M., McKeating J.A. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Nat. Acad. Sci. U.S.A 2003, 100:7271-7276.
21. Hudson R.R., Boos D.D., Kaplan N.L. A statistical test for detecting geographic subdivision. Mol. Biol. Evol. 1992, 9:138-151.
22. Hudson R.R., Kaplan N.L. Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics 1985, 111:147-164.
23. Hudson R.R, Slatkin M., Maddison W.P. Estimation of levels of gene flow from DNA sequence data. Genetics 1992, 132:583-589.
24. Kalinina O., Norder H., Mukomolov S., Magnius L.O. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J. Virol. 2002, 76:4034-4043.
25. Katoh K., Kuma K., Toh H., Miyata T. MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 2005, 33:511-518.
26. Kosakovsky Pond S.L., Frost S.D.W. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 2005, 22:1208-1222.
27. Kosakovsky Pond S.L., Murrell B., Fourment M., Frost S.D.W., Delport W., Scheffler K. A random effects branch-site model for detecting episodic diversifying selection. Mol. Biol. Evol. 2011, 28:3033-3043.
28. Kuiken C., Simmonds P. Nomenclature and numbering of the hepatitis C virus. Methods Mol. Biol. 2009, 510:33-53.
29. Lavillette D., Morice Y., Germanidis G., Donot P., Soulier A., Pagkalos E., Sakellariou G., Intrator L., Bartosch B., Pawlotsky J.M., Cosset F.L. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J. Virol. 2005, 79:6023-6034.
30. Lavillette D., Pecheur E.I., Donot P., Fresquet J., Molle J., Corbau R., Dreux M., Penin F., Cosset F.L. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J. Virol. 2007, 81:8752-8765.
31. Librado P., Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 2009, 25:1451-1452.
32. Logvinoff C., Major M.E., Oldach D., Heyward S., Talal A., Balfe P., Feinstone S.M., Alter H., Rice C.M., McKeating J.A. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc. Nat. Acad. Sci. U.S.A 2004, 101:10149.
33. McDonald J.H., Kreitman M. Adaptive protein evolution at the Adh locus in Drosophila. Nature 1991, 351:652-654.
34. Moreno P., Alvarez M., López L., Moratorio G., Casane D., Castells M., Castro S., Cristina J., Colina R. Evidence of recombination in hepatitis C virus populations infecting a hemophiliac patient. Virol. J. 2009, 6:203.
35. Nei M., Tajima F. Genetic drift and estimation of effective population size. Genetics 1981, 98:625-640.
36. Netski D.M., Mosbruger T., Depla E., Maertens G., Ray S.C., Hamilton R.G., Roundtree S., Thomas D.L., McKeating J., Cox A. Humoral immune response in acute hepatitis C virus infection. Clin. Infect. Dis. 2005, 41:667-675.
37. Noppornpanth S., Lien T.X., Poovorawan Y., Smits S.L., Osterhaus A.D.M.E., Haagmans B.L. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J. Virol. 2006, 80:7569-7577.
38. Pestka J.M., Zeisel M.B., Bläser E., Schürmann P., Bartosch B., Cosset F.L., Patel A.H., Meisel H., Baumert J., Viazov S., Rispeter K., Blum H.E., Roggendorf M., Baumert T.F. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc. Nat. Acad. Sci. U.S.A 2007, 104:6025-6030.
39. Raghuraman S., Park H., Osburn W.O., Winkelstein E., Edlin B.R., Rehermann B. Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. J. Infect. Dis. 2012, 205:763-771.
40. Ray S.C., Wang Y.M., Laeyendecker O., Ticehurst J.R., Villano S.A., Thomas D.L. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J. Virol. 1999, 73:2938-2946.
41. Robertson B., Myers G., Howard C., Brettin T., Bukh J., Gaschen B., Gojobori T., Maertens G., Mizokami M., Nainan O., Netesov S., Nishioka K., Shin I.T., Simmonds P., Smith D., Stuyver L., Weiner A. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch. Virol. 1998, 143:2493-2503.
42. Scheffler K., Martin D.P., Seoighe C. Robust inference of positive selection from recombining coding sequences. Bioinformatics 2006, 22:2493-2499.
43. Simmonds P., Bukh J., Combet C., Deléage G., Enomoto N., Feinstone S., Halfon P., Inchauspé G., Kuiken C., Maertens G., Mizokami M., Murphy D.G., Okamoto H., Pawlotsky J., Penin F., Sablon E., Shin I.T., Stuyver L.J., Thiel H., Viazov S., Weiner A.J., Widell A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005, 42:962-973.
44. von Hahn T., Yoon J.C., Alter H., Rice C.M., Rehermann B., Balfe P., McKeating J.A. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 2007, 132:667-678.
45. Weseslindtner L., Neumann-Haefelin C., Viazov S., Haberstroh A., Kletzmayr J., Aberle J.H., Timm J., Ross S.R., Klauser-Braun R., Baumert T.F., Roggendorf M., Thimme R., Holzmann H. Acute infection with a single hepatitis C virus strain in dialysis patients: analysis of adaptive immune response and viral variability. J. Hepatol. 2009, 50:693-704.
46. Zeisel M.B., Fafi-Kremer S., Fofana I., Barth H., Stoll-Keller F., Doffoel M., Baumert T.F. Neutralizing antibodies in hepatitis C virus infection. World J. Gastroenterol. 2007, 13:4824-4830.
47. Zhang J., Randall G., Higginbottom A., Monk P., Rice C.M., McKeating J.A. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 2004, 78:1448-1455.